Invested Capital Turns: Explanation and Examples

Invested capital turns are an important consideration in the analysis of return on invested capital (ROIC) and a key measure of balance sheet efficiency.

Continue Reading →

New Stocks in September’s Exec Comp Aligned with ROIC Model Portfolio

The best performing stock in last month’s portfolio was Children’s Place (PLCE) which was up 15%. Get a free look at a new stock in September’s Model Portfolio.

Continue Reading →

Taking GAAP Earnings at Face Value Puts Investors at Risk

The more investors understand about how GAAP net income omits valuable information, the better equipped they are to find truly hidden gems, or those companies with growing economic earnings and undervalued stock prices.

Continue Reading →

Alpha-generating Forensic Accounting Examples

New Constructs’ proprietary forensic accounting research empowers investors to identify alpha-generating investment ideas more efficiently than traditional manual approaches. This report highlights investment ideas based on insights our research technology automatically provides on a firm’s true return on invested capital (ROIC) and economic earnings.

Continue Reading →

The Earnings Recovery Remains an Illusion

Earnings Recovery Illusion

Our analysis of the latest 10-K and 10-Q filings for the S&P 500 shows that the GAAP earnings growth in the market has not translated to an increase in economic earnings.

Continue Reading →

Value Investing Is Not Dead, But It Is Harder

We think today’s market is the best in many years for value investors, the real value investors, that is. The real value investors analyze footnotes and balance sheets in addition to income statements. 

Continue Reading →

Webinar: “New Age” Analysis – Equity and Fixed Income Research Synergies

Looking for forensic accounting diligence in footnotes and other disclosures to improve risk management? Get answers to this topic and more from New Constructs and Viola Risk Advisors’ co-hosted webinar.

Continue Reading →

The Earnings Recovery Is A Sham

Our analysis of the latest 10-K filings for the 2,600 largest and most actively-traded companies shows that the much-hyped end to the earnings recession is an accounting illusion.

Continue Reading →

Filing Season Finds: Wednesday, February 22

Yesterday, our analysts parsed 56 filings and collected 7,941 data points. In total, they made 1,335 adjustments with a dollar value of $351 billion. In particular, analyst Hunter Gray found an unusual item in Phillips 66’s (PSX) 10-K.

Continue Reading →

“This is the earnings metric stock-market investors should focus on”

On Wednesday ( 10/12/16) our op-ed article was published at Marketwatch. The article explains why investors need to look past common metrics such as EPS or non-GAAP earnings

Continue Reading →

Danger Zone: Zoe’s Kitchen (ZOES)

Declining economic earnings, weak competitive position, and an overvalued stock land Zoe’s Kitchen (ZOES) in the Danger Zone this week.

Continue Reading →

Danger Zone: 8×8 (EGHT)

This week’s Danger Zone is a company that claims consistent profitability and continued success, despite years of shareholder value destruction. Misleading non-GAAP results, large losses, and an overvalued stock price land 8×8 in the Danger Zone.

Continue Reading →

Danger Zone: Interactive Intelligence (ININ)

But what happens when a once profitable company makes the transition to the cloud and has become largely unprofitable? That company, Interactive Intelligence (ININ) is in the Danger Zone this week.

Continue Reading →

The SEC Is Starting To Worry About Non-GAAP Earnings

We’ve been sounding the alarm on non-GAAP earnings for several years now. Companies exploited the wide leeway granted by the SEC to present their business in a more favorable light.

Continue Reading →

Economic Earnings: Explanation & Examples

To derive economic earnings, 30+ adjustments must be made to accounting earnings. These adjustments remove items hidden in the footnotes and MD&A of annual filings and close loopholes within GAAP accounting.

Continue Reading →

Danger Zone: Compensation Committees

We know that Valeant is not the only company with misaligned executive incentives. There are many others, many of which have already been put in the Danger Zone and some who will go into the Danger Zone soon. This week, however, compensation committees land in the Danger Zone because of the role they play in creating the problems that lead to shareholder value destruction.

Continue Reading →

Danger Zone: Valeant Pharmaceuticals (VRX)

We’ve been highlighting the dangers of Valeant for over two years and we do not see them abating. As long as management is incentivized to destroy shareholder value, Valeant is in the Danger Zone.

Continue Reading →

The Ugly Truth About Netflix: Investors Beware

It is almost becoming an expected event every quarter: Netflix releases quarterly earnings amid much speculation about its future, and the price soars.

Continue Reading →

How to Value a Stock, Step 3: Economic Earnings

This article is the third in a four part series that walks readers through how to rate and value a stock. Our third step to gauge the value of a company is to determine its economic earnings.

Continue Reading →

GAAP Opinion versus Economic Fact

GAAP financial statements generally fail to meet equity investors’ analytical needs. We try to calculate something that does.

Continue Reading →

Page 1 of 5